SLC2A1-DT: A Protein Implicated in A Number of Diseases and Disorders

Target Name: SLC2A1-DT

NCBI ID: G440584

Other Name(s): RP5-848E13.3 | SLC2A1-AS1 | SLC2A1 divergent transcript

SLC2A1-DT: A Protein Implicated in A Number of Diseases and Disorders

SLC2A1-DT (RP5-848E13.3) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the SLC2A1 family, which is known for its role in the transport of various molecules across cell membranes. SLC2A1-DT has been shown to play a role in a number of physiological processes, including blood pressure regulation, inflammation, and neurodegeneration.

One of the unique features of SLC2A1-DT is its ability to interact with several different drugs, including those that are used to treat a wide range of diseases. This makes it an attractive target for researchers to study, as it allows them to study the effects of these drugs on SLC2A1-DT and its role in the development of various diseases.

SLC2A1-DT has also been shown to be involved in a number of diseases and disorders, including neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. These diseases are characterized by the progressive loss of brain cells and the development of hallucinations, memory loss, and other cognitive impairments. SLC2A1-DT has been shown to be involved in the development and progression of these diseases, and may be a useful drug target for the development of new treatments.

In addition to its potential role in neurodegenerative diseases, SLC2A1-DT is also involved in a number of other physiological processes that are important for human health. For example, it has been shown to play a role in blood pressure regulation, which is important for maintaining the health of the cardiovascular system. SLC2A1-DT has also been shown to be involved in the regulation of inflammation, which is important for maintaining the health of the immune system and preventing the development of diseases such as cancer.

SLC2A1-DT is also of interest because of its expression in a number of different tissues, including the brain. This suggests that it may be involved in a number of different processes that are important for brain development and function. SLC2A1-DT has also been shown to play a role in the development and progression of a number of brain disorders, including Alzheimer's and Parkinson's diseases. These disorders are characterized by the progressive loss of brain cells and the development of hallucinations, memory loss, and other cognitive impairments. SLC2A1-DT has been shown to be involved in the development and progression of these disorders, and may be a useful target for the development of new treatments.

In conclusion, SLC2A1-DT is a protein that is expressed in various tissues throughout the body and is involved in a number of important physiological processes. Its ability to interact with several different drugs and its involvement in a number of diseases and disorders make it an attractive target for researchers to study. Further research is needed to fully understand the role of SLC2A1-DT in these processes and its potential as a drug target.

Protein Name: SLC2A1 Divergent Transcript

More Common Targets